171 - 180 of 7916 Results
Title
Year
- Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset2024OPENTitle: Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onsetJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-48961-3Best OA location URL: https://www.nature.com/articles/s41467-024-48961-3.pdfCitation Count: 5
- Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease2024OPENTitle: Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson diseaseJournal Name: Nature Mental HealthPublisher: Springer Science and Business Media LLCVol: 2Issue #: 8Start Page: 916End Page: 923Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s44220-024-00256-8Citation Count: 0
- Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates2024OPENTitle: Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primatesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00735-wBest OA location URL: https://www.nature.com/articles/s41531-024-00735-w.pdfCitation Count: 0
- Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology2024OPENTitle: Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathologyJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49402-xBest OA location URL: https://doi.org/10.1038/s41467-024-49402-xCitation Count: 3
-
OPENTitle: Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathiesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49258-1Citation Count: 0
- Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimetic2024OPENTitle: Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimeticJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 6Start Page: e0304603End Page: e0304603Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0304603Citation Count: 0
- An Ethnographic Study of Patient Life Experience in Early-Stage Parkinson’s Disease in the United States and Germany2024OPENTitle: An Ethnographic Study of Patient Life Experience in Early-Stage Parkinson’s Disease in the United States and GermanyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 4Start Page: 1219End Page: 1235Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-024-00632-7Citation Count: 0
- Fox Insight at 5 years - a cohort of 54,000 participants contributing longitudinal patient-reported outcome, genetic, and microbiome data relating to Parkinson’s disease2024OPENTitle: Fox Insight at 5 years - a cohort of 54,000 participants contributing longitudinal patient-reported outcome, genetic, and microbiome data relating to Parkinson’s diseaseJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-024-03407-9Citation Count: 0
- Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study over 12 months2024OPENTitle: Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study over 12 monthsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00721-2Citation Count: 0
- DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease2024OPENTitle: DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-024-00421-0Citation Count: 0